Nifty

:

23913.70

Sensex

:

76009.70

-118.00 (-0.49%)
-479.26 (-0.63%)

Login

Nifty
Sensex

:
:

23913.70
76009.70

-118.00 (-0.49%)
-479.26 (-0.63%)

Advanced Enzyme Technologies Ltd.

Pharmaceuticals & Drugs - Global

Rating :

59/99

BSE: 540025 | NSE: ADVENZYMES

Watchlist

NSE BSE

376.85

25-May-2026

Open
High
Low
Previous Close

380.9
387.6
375.3
375.15

Volume
Traded Value (lacs)
52 Week High
52 Week Low

134842
51332622.15
419
251.95

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,215.90
24.99
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,213.56
0.36%
2.58

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

8.05
4.88
5.61

EBITDA CAGR (%)

10 Years
5 Years
3 Years

3.58
-3.41
4.42

PAT CAGR (%)

10 Years
5 Years
3 Years

5.63
-2.12
7.47

P:E (Median)

8 Years
5 Years
3 Years

27.03
29.09
29.09

P:BV (Average)

8 Years
5 Years
3 Years

3.10
3.02
2.83

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.61
16.12
16.24

Earnings Forecasts:

(Updated: 23-05-2026)

Description 2024 2025 2026 2027
Adj EPS 13.6 15.5 18.4 20.71
P/E Ratio 27.71 24.31 20.48 18.20
Revenue 730.4 853.5 997 1147.2
EBITDA 222.1 259 301.7 345.8
Net Income 152.4 172.9 205.3 231.6
ROA
P/B Ratio 2.69 2.51 2.42
ROE 10.4 11.1 12.2 12.8
FCFF 149.75 104.11 142.82 184.57
FCFF Yield 4.01 2.79 3.82 4.94
Net Debt -648.6 -663.5 -651.1 -744.6
BVPS 139.91 149.98 155.5

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 116.41 87.21 33.48% 95.58 100.87 -5.24% 115.75 77.38 49.59% 125.02 85.96 45.44%
Expenses 89.55 73.04 22.60% 72.12 78.81 -8.49% 86.16 63.85 34.94% 94.50 65.04 45.30%
EBITDA 26.86 14.17 89.56% 23.46 22.06 6.35% 29.59 13.53 118.70% 30.53 20.92 45.94%
EBIDTM 23.07% 16.25% 24.55% 21.87% 25.57% 17.48% 24.42% 24.34%
Other Income 5.16 4.53 13.91% 1.29 1.43 -9.79% 3.08 1.66 85.54% 53.85 53.88 -0.06%
Interest 0.06 0.08 -25.00% 0.05 0.06 -16.67% 0.05 0.08 -37.50% 0.05 0.02 150.00%
Depreciation 3.11 3.11 0.00% 3.04 2.89 5.19% 3.00 2.78 7.91% 2.93 2.62 11.83%
PBT 28.84 15.51 85.94% 17.82 20.54 -13.24% 29.62 12.32 140.42% 81.40 72.16 12.80%
Tax 6.55 4.46 46.86% 4.57 5.36 -14.74% 7.34 3.19 130.09% 7.42 5.10 45.49%
PAT 22.29 11.05 101.72% 13.25 15.18 -12.71% 22.28 9.13 144.03% 73.98 67.06 10.32%
PATM 19.15% 12.68% 13.86% 15.05% 19.25% 11.79% 59.17% 78.01%
EPS 1.99 0.99 101.01% 1.18 1.36 -13.24% 1.99 0.82 142.68% 6.61 5.99 10.35%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 203.37 167.18 21.65% 171.95 169.11 1.68% 184.53 146.09 26.31% 185.91 154.52 20.31%
Expenses 140.14 121.58 15.27% 122.60 113.86 7.68% 124.47 103.68 20.05% 129.48 103.36 25.27%
EBITDA 63.23 45.60 38.66% 49.35 55.25 -10.68% 60.05 42.42 41.56% 56.43 51.17 10.28%
EBIDTM 31.09% 27.28% 28.70% 32.67% 32.55% 29.03% 30.35% 33.11%
Other Income 7.23 8.75 -17.37% 8.47 7.68 10.29% 10.28 9.62 6.86% 8.85 6.99 26.61%
Interest 0.57 0.81 -29.63% 0.57 0.94 -39.36% 0.72 0.93 -22.58% 0.76 0.87 -12.64%
Depreciation 10.19 10.08 1.09% 10.21 8.97 13.82% 10.08 8.89 13.39% 9.62 8.61 11.73%
PBT 59.80 43.46 37.60% 58.29 53.02 9.94% 59.54 42.21 41.06% 54.90 48.67 12.80%
Tax 14.55 16.73 -13.03% 15.11 14.14 6.86% 14.81 8.82 67.91% 14.46 13.70 5.55%
PAT 45.25 26.73 69.29% 43.18 38.88 11.06% 44.73 33.39 33.96% 40.44 34.98 15.61%
PATM 22.25% 15.99% 25.11% 22.99% 24.24% 22.86% 21.75% 22.63%
EPS 3.84 2.37 62.03% 3.80 3.36 13.10% 3.87 2.94 31.63% 3.57 3.05 17.05%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 452.76 351.41 365.47 311.53 272.80 283.47 247.35 222.09 212.06 172.64 139.14 Net Sales Growth 28.84% -3.85% 17.31% 14.20% -3.76% 14.60% 11.37% 4.73% 22.83% 24.08% Cost Of Goods Sold 184.63 142.33 131.73 122.91 99.20 96.30 88.76 85.83 85.51 62.10 43.99 Gross Profit 268.13 209.08 233.74 188.62 173.60 187.16 158.60 136.26 126.55 110.54 95.15 GP Margin 59.22% 59.50% 63.96% 60.55% 63.64% 66.02% 64.12% 61.35% 59.68% 64.03% 68.38% Total Expenditure 342.33 280.46 260.18 236.45 199.97 182.62 170.40 169.21 162.66 124.14 102.82 Power & Fuel Cost - 19.04 23.29 19.98 16.64 11.94 11.30 10.55 10.59 10.64 9.73 % Of Sales - 5.42% 6.37% 6.41% 6.10% 4.21% 4.57% 4.75% 4.99% 6.16% 6.99% Employee Cost - 56.03 49.39 41.42 39.32 34.23 32.61 32.89 32.48 27.34 24.34 % Of Sales - 15.94% 13.51% 13.30% 14.41% 12.08% 13.18% 14.81% 15.32% 15.84% 17.49% Manufacturing Exp. - 19.42 18.01 14.12 13.08 8.84 8.73 7.02 7.91 6.97 8.89 % Of Sales - 5.53% 4.93% 4.53% 4.79% 3.12% 3.53% 3.16% 3.73% 4.04% 6.39% General & Admin Exp. - 27.15 26.11 25.37 22.61 23.65 21.33 25.55 17.61 10.07 7.93 % Of Sales - 7.73% 7.14% 8.14% 8.29% 8.34% 8.62% 11.50% 8.30% 5.83% 5.70% Selling & Distn. Exp. - 11.23 7.53 7.00 6.04 4.84 4.41 4.57 5.72 4.57 4.08 % Of Sales - 3.20% 2.06% 2.25% 2.21% 1.71% 1.78% 2.06% 2.70% 2.65% 2.93% Miscellaneous Exp. - 5.25 4.13 5.64 3.08 2.81 3.26 2.80 2.83 2.46 4.08 % Of Sales - 1.49% 1.13% 1.81% 1.13% 0.99% 1.32% 1.26% 1.33% 1.42% 2.77% EBITDA 110.44 70.95 105.29 75.08 72.83 100.85 76.95 52.88 49.40 48.50 36.32 EBITDA Margin 24.39% 20.19% 28.81% 24.10% 26.70% 35.58% 31.11% 23.81% 23.30% 28.09% 26.10% Other Income 63.38 61.49 58.94 9.81 9.08 6.82 9.00 5.61 5.63 6.42 0.93 Interest 0.21 0.51 0.39 0.33 0.27 0.24 1.29 2.72 3.37 2.94 4.37 Depreciation 12.08 11.40 10.90 10.28 9.56 9.01 8.81 8.56 7.81 8.33 7.38 PBT 157.68 120.53 152.94 74.28 72.07 98.43 75.85 47.20 43.84 43.65 25.49 Tax 25.88 18.11 25.87 18.75 17.56 27.42 17.90 11.97 7.95 9.08 4.59 Tax Rate 16.41% 15.03% 19.31% 25.24% 24.37% 27.86% 23.60% 25.36% 18.13% 20.80% 18.01% PAT 131.80 102.42 108.12 55.53 54.51 71.01 57.95 35.23 35.89 34.57 20.89 PAT before Minority Interest 131.80 102.42 108.12 55.53 54.51 71.01 57.95 35.23 35.89 34.57 20.89 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 29.11% 29.15% 29.58% 17.82% 19.98% 25.05% 23.43% 15.86% 16.92% 20.02% 15.01% PAT Growth 28.69% -5.27% 94.71% 1.87% -23.24% 22.54% 64.49% -1.84% 3.82% 65.49% EPS 11.78 9.15 9.66 4.96 4.87 6.35 5.18 3.15 3.21 3.09 1.87

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 745.76 636.91 623.87 540.64 529.38 501.84 443.99 419.59 391.01 328.99 293.76 Net Sales Growth 17.09% 2.09% 15.39% 2.13% 5.49% 13.03% 5.82% 7.31% 18.85% 11.99% Cost Of Goods Sold 192.95 151.86 144.58 131.81 109.71 99.05 80.91 77.24 81.47 71.03 61.67 Gross Profit 552.81 485.05 479.29 408.83 419.66 402.80 363.08 342.35 309.54 257.96 232.09 GP Margin 74.13% 76.16% 76.83% 75.62% 79.27% 80.26% 81.78% 81.59% 79.16% 78.41% 79.01% Total Expenditure 516.69 441.40 418.53 383.14 326.81 269.26 240.85 237.03 227.48 177.54 156.20 Power & Fuel Cost - 37.95 40.92 38.10 29.95 21.45 19.37 19.63 18.40 13.20 10.17 % Of Sales - 5.96% 6.56% 7.05% 5.66% 4.27% 4.36% 4.68% 4.71% 4.01% 3.46% Employee Cost - 141.54 127.78 114.80 103.96 87.11 80.19 78.05 68.59 50.70 44.50 % Of Sales - 22.22% 20.48% 21.23% 19.64% 17.36% 18.06% 18.60% 17.54% 15.41% 15.15% Manufacturing Exp. - 33.60 33.57 27.78 23.87 17.51 16.86 11.89 12.36 9.50 10.98 % Of Sales - 5.28% 5.38% 5.14% 4.51% 3.49% 3.80% 2.83% 3.16% 2.89% 3.74% General & Admin Exp. - 38.87 41.19 37.25 33.67 27.03 26.05 31.65 28.03 18.05 15.72 % Of Sales - 6.10% 6.60% 6.89% 6.36% 5.39% 5.87% 7.54% 7.17% 5.49% 5.35% Selling & Distn. Exp. - 24.32 17.97 17.54 16.74 9.40 10.56 9.66 9.57 7.55 7.29 % Of Sales - 3.82% 2.88% 3.24% 3.16% 1.87% 2.38% 2.30% 2.45% 2.29% 2.48% Miscellaneous Exp. - 13.25 12.50 15.86 8.90 7.72 6.91 8.92 9.04 7.50 7.29 % Of Sales - 2.08% 2.00% 2.93% 1.68% 1.54% 1.56% 2.13% 2.31% 2.28% 1.99% EBITDA 229.06 195.51 205.34 157.50 202.57 232.58 203.14 182.56 163.53 151.45 137.56 EBITDA Margin 30.71% 30.70% 32.91% 29.13% 38.27% 46.35% 45.75% 43.51% 41.82% 46.03% 46.83% Other Income 34.83 33.04 36.97 25.46 6.42 8.85 5.88 5.72 2.79 2.79 1.29 Interest 2.62 4.63 4.12 3.48 2.96 2.57 4.08 5.20 9.06 4.43 7.86 Depreciation 40.10 36.56 35.24 35.03 34.98 28.72 25.78 21.12 18.30 12.76 8.72 PBT 232.53 187.36 202.95 144.45 171.06 210.13 179.16 161.96 138.97 137.05 122.28 Tax 58.93 53.39 50.87 36.52 47.26 58.84 46.11 46.06 45.41 44.11 41.43 Tax Rate 25.34% 28.50% 27.08% 26.01% 27.63% 28.00% 25.74% 28.44% 32.68% 32.19% 35.06% PAT 173.60 131.11 133.30 105.64 119.58 145.93 129.30 111.06 90.16 91.52 75.85 PAT before Minority Interest 168.71 133.97 136.95 103.87 123.80 151.29 133.05 115.90 93.56 92.94 76.75 Minority Interest -4.89 -2.86 -3.65 1.77 -4.22 -5.36 -3.75 -4.84 -3.40 -1.42 -0.90 PAT Margin 23.28% 20.59% 21.37% 19.54% 22.59% 29.08% 29.12% 26.47% 23.06% 27.82% 25.82% PAT Growth 29.57% -1.64% 26.18% -11.66% -18.06% 12.86% 16.42% 23.18% -1.49% 20.66% EPS 15.51 11.72 11.91 9.44 10.69 13.04 11.55 9.92 8.06 8.18 6.78

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 629.34 580.47 525.33 480.35 435.45 370.48 319.47 288.90 255.23 174.20 Share Capital 22.38 22.36 22.36 22.36 22.35 22.34 22.33 22.33 22.33 21.77 Total Reserves 602.01 555.08 502.97 457.35 410.48 344.54 293.62 263.94 232.60 152.44 Non-Current Liabilities 14.59 12.45 13.57 12.96 13.11 11.09 6.06 10.03 15.08 31.54 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.05 0.20 5.53 8.82 11.38 Unsecured Loans 0.00 0.00 0.00 0.00 0.18 0.72 1.49 2.41 3.31 4.23 Long Term Provisions 0.82 0.66 0.32 0.86 0.99 1.08 0.51 0.56 0.70 0.18 Current Liabilities 44.70 40.01 36.90 36.31 41.04 35.63 44.98 70.02 43.66 54.84 Trade Payables 22.68 21.72 18.13 20.26 22.53 13.71 15.58 21.20 8.48 8.99 Other Current Liabilities 18.20 15.46 16.48 13.91 16.24 11.94 11.19 13.90 12.39 14.95 Short Term Borrowings 0.00 0.00 0.01 0.00 0.14 7.86 16.51 32.33 21.13 29.45 Short Term Provisions 3.83 2.83 2.28 2.14 2.13 2.12 1.70 2.59 1.66 1.45 Total Liabilities 688.63 632.93 575.80 529.62 489.60 417.20 370.51 368.95 313.97 260.58 Net Block 156.50 142.13 142.86 132.03 132.22 126.95 97.35 97.87 98.38 101.28 Gross Block 237.85 212.87 203.62 183.45 174.10 160.06 121.78 113.87 106.66 170.14 Accumulated Depreciation 81.35 70.74 60.76 51.42 41.88 33.11 24.43 16.00 8.28 68.86 Non Current Assets 456.43 384.59 386.26 352.94 329.37 292.50 268.89 264.00 217.27 179.38 Capital Work in Progress 20.75 21.86 11.03 8.68 7.34 9.96 7.00 10.31 8.05 6.90 Non Current Investment 253.71 205.49 185.48 172.68 151.56 119.84 120.46 120.03 103.41 53.08 Long Term Loans & Adv. 19.46 14.73 38.36 35.76 35.14 34.04 38.80 33.27 6.30 17.99 Other Non Current Assets 6.01 0.39 8.54 3.79 3.12 1.71 5.28 2.52 1.13 0.13 Current Assets 232.20 248.34 189.54 176.69 160.23 125.36 102.18 104.18 95.44 81.20 Current Investments 36.65 50.80 15.99 16.68 32.92 1.00 0.00 0.00 0.00 0.00 Inventories 101.45 96.88 76.79 80.08 63.42 59.65 58.62 54.86 51.06 47.40 Sundry Debtors 78.17 75.17 66.67 49.09 54.74 51.89 38.15 38.58 30.97 22.78 Cash & Bank 5.83 2.02 24.72 17.98 1.87 3.02 0.54 0.48 0.60 1.54 Other Current Assets 10.10 3.04 1.89 4.50 7.27 9.79 4.89 10.26 12.82 9.48 Short Term Loans & Adv. 8.03 20.43 3.48 8.36 3.85 5.80 2.33 5.69 11.19 1.99 Net Current Assets 187.50 208.33 152.64 140.38 119.19 89.73 57.20 34.16 51.78 26.36 Total Assets 688.63 632.93 575.80 529.63 489.60 417.86 371.07 368.18 312.71 260.58

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,420.86 1,324.13 1,235.07 1,088.59 970.94 839.65 678.85 559.08 464.05 278.09 Share Capital 22.38 22.36 22.36 22.36 22.35 22.34 22.33 22.33 22.33 21.77 Total Reserves 1,393.53 1,298.73 1,212.70 1,065.59 945.97 813.71 652.99 534.12 441.42 256.32 Non-Current Liabilities 45.73 43.74 48.77 59.38 49.13 38.71 29.88 42.84 32.22 56.11 Secured Loans 9.18 6.96 7.80 8.13 9.70 3.44 5.55 17.42 16.18 34.53 Unsecured Loans 0.00 0.00 0.00 0.00 0.18 0.72 1.49 2.41 3.31 4.23 Long Term Provisions 1.37 0.89 0.51 1.07 1.36 1.30 0.55 1.12 0.79 0.18 Current Liabilities 96.75 106.36 77.57 60.42 67.56 59.55 65.12 98.83 61.70 110.76 Trade Payables 17.20 15.76 24.22 17.90 15.22 9.64 9.69 17.47 11.01 11.54 Other Current Liabilities 42.45 44.20 43.15 36.59 43.41 33.52 28.96 37.92 21.34 59.29 Short Term Borrowings 11.14 17.58 4.99 1.92 4.69 12.74 21.34 37.81 26.54 29.63 Short Term Provisions 25.96 28.82 5.20 4.02 4.23 3.64 5.12 5.63 2.80 10.29 Total Liabilities 1,611.15 1,521.18 1,410.51 1,260.18 1,149.31 965.71 799.81 723.35 579.11 450.31 Net Block 678.67 649.75 649.06 619.11 604.18 562.87 495.46 491.29 421.36 285.46 Gross Block 965.78 902.23 867.77 805.88 756.25 681.35 586.46 560.96 445.12 357.86 Accumulated Depreciation 287.11 252.49 218.71 186.77 152.07 118.48 91.00 69.67 23.77 72.40 Non Current Assets 731.29 711.44 688.40 655.75 633.29 590.79 518.30 511.88 439.68 310.59 Capital Work in Progress 21.71 41.10 21.50 15.07 10.24 10.13 10.49 10.54 8.05 6.90 Non Current Investment 0.07 0.17 0.17 0.07 0.07 0.06 0.06 0.06 0.06 0.06 Long Term Loans & Adv. 23.78 18.96 16.34 17.50 14.88 16.68 11.27 8.93 9.08 18.04 Other Non Current Assets 7.06 1.46 1.33 4.00 3.92 1.05 1.01 1.06 1.13 0.13 Current Assets 879.87 809.74 722.11 604.44 516.01 375.57 282.06 210.71 138.16 139.72 Current Investments 480.26 402.85 359.55 101.95 121.31 123.53 110.98 0.00 0.00 0.00 Inventories 157.31 148.46 123.99 120.92 93.88 80.03 76.90 75.57 68.48 60.49 Sundry Debtors 115.40 98.57 100.34 88.21 86.27 74.69 58.73 58.59 49.82 41.80 Cash & Bank 107.69 126.95 123.35 273.63 197.77 83.02 23.41 61.42 7.87 26.31 Other Current Assets 19.22 8.86 6.22 7.76 16.77 14.30 12.04 15.12 11.99 11.11 Short Term Loans & Adv. 10.74 24.06 8.66 11.97 7.63 6.56 2.74 6.62 8.93 3.30 Net Current Assets 783.11 703.38 644.54 544.01 448.46 316.03 216.94 111.88 76.47 28.96 Total Assets 1,611.16 1,521.18 1,410.51 1,260.19 1,149.30 966.36 800.36 722.59 577.84 450.31

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 63.48 51.63 50.30 37.10 84.23 45.98 35.37 22.59 21.05 22.33 PBT 120.53 133.99 74.28 72.07 98.43 75.85 47.20 43.84 43.65 25.49 Adjustment -43.70 -23.59 5.07 1.68 3.56 3.21 6.71 8.84 6.30 11.19 Changes in Working Capital 8.19 -31.57 -12.60 -15.21 9.07 -20.38 -6.17 -21.45 -18.85 -8.63 Cash after chg. in Working capital 85.02 78.84 66.75 58.54 111.06 58.67 47.74 31.22 31.11 28.05 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -21.55 -27.21 -16.45 -21.44 -26.83 -12.70 -12.37 -8.64 -10.05 -5.72 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1.74 -2.70 -42.35 -14.24 -69.91 -24.94 -1.91 -22.05 -54.84 -26.53 Net Fixed Assets -23.87 -20.08 -22.52 -10.69 -11.42 -41.24 -4.60 -9.47 62.33 -5.70 Net Investments -34.07 -54.82 -12.11 -4.88 -63.64 -0.38 -0.43 -16.62 -50.33 -25.76 Others 56.20 72.20 -7.72 1.33 5.15 16.68 3.12 4.04 -66.84 4.93 Cash from Financing Activity -57.63 -56.88 -11.99 -10.87 -15.49 -18.56 -33.47 -0.61 33.54 3.90 Net Cash Inflow / Outflow 4.11 -7.95 -4.05 11.99 -1.16 2.48 0.00 -0.08 -0.24 -0.31 Opening Cash & Equivalents 1.50 9.45 13.50 1.50 2.67 0.19 0.19 0.27 0.52 0.83 Closing Cash & Equivalent 5.60 1.50 9.45 13.50 1.50 2.67 0.19 0.19 0.27 0.52

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 142.50 141.37 140.36 122.29 162.97 140.90 128.56 115.97 107.35 93.40 PBT 187.36 187.82 140.39 171.06 210.13 179.16 161.96 138.97 137.05 118.18 Adjustment 27.04 29.04 36.95 33.16 24.57 28.23 26.02 27.15 18.31 15.35 Changes in Working Capital -12.23 -26.25 -0.34 -27.40 -15.03 -15.60 -12.10 -5.64 4.43 -13.10 Cash after chg. in Working capital 202.17 190.60 177.00 176.82 219.68 191.79 175.88 160.48 159.80 120.43 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -59.67 -49.23 -36.64 -54.53 -56.71 -50.89 -47.32 -44.51 -52.45 -27.03 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -89.10 -64.65 -298.18 -3.79 -26.03 -44.50 -124.65 -78.19 -60.35 -4.73 Net Fixed Assets -23.87 -20.08 -22.52 -10.69 -11.42 -41.24 -4.60 -9.47 62.33 -5.70 Net Investments -34.07 -54.82 -12.11 -4.88 -63.64 -0.38 -0.43 -16.62 -50.33 -25.76 Others -31.16 10.25 -263.55 11.78 49.03 -2.88 -119.62 -52.10 -72.35 26.73 Cash from Financing Activity -72.54 -59.24 -25.80 -48.50 -26.39 -38.55 -43.09 -2.07 -65.30 -62.58 Net Cash Inflow / Outflow -19.15 17.48 -183.62 70.00 110.55 57.85 -39.17 35.72 -18.30 26.09 Opening Cash & Equivalents 113.75 96.42 267.36 191.92 82.66 23.06 61.13 7.50 25.30 4.21 Closing Cash & Equivalent 94.22 113.75 96.42 267.36 191.92 82.66 23.06 61.13 7.54 25.30

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 55.81 51.64 46.98 42.91 38.74 32.85 28.30 25.64 22.84 16.01 ROA 15.50% 17.89% 10.05% 10.70% 15.57% 14.51% 9.41% 10.39% 11.96% 8.65% ROE 17.04% 19.61% 11.05% 11.95% 17.76% 16.98% 11.70% 13.26% 16.11% 12.66% ROCE 20.01% 24.30% 14.83% 15.78% 24.16% 21.45% 14.85% 15.07% 18.06% 14.31% Fixed Asset Turnover 1.56 1.76 1.61 1.53 1.72 1.73 1.85 1.91 1.33 0.88 Receivable days 79.64 70.67 67.63 69.18 67.59 66.42 63.05 58.95 53.38 58.19 Inventory Days 103.00 86.53 91.65 95.62 78.01 87.25 93.25 89.78 97.78 106.63 Payable days 56.93 55.22 57.00 78.71 68.67 33.71 43.62 36.10 25.97 30.35 Cash Conversion Cycle 125.71 101.99 102.29 86.09 76.93 119.96 112.67 112.63 125.18 134.47 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.03 0.06 0.16 0.15 0.28 Interest Cover 239.20 347.23 226.08 265.97 414.56 59.71 18.34 14.01 15.87 6.83

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 126.56 118.14 110.45 97.31 86.67 74.86 60.49 49.85 41.54 25.55 ROA 8.55% 9.34% 7.78% 10.28% 14.27% 14.98% 15.13% 14.28% 18.00% 17.81% ROE 9.79% 10.72% 8.94% 12.04% 16.77% 17.61% 18.82% 18.34% 25.06% 31.32% ROCE 13.76% 14.78% 12.26% 16.66% 22.93% 23.21% 24.96% 25.88% 31.53% 35.68% Fixed Asset Turnover 0.68 0.71 0.65 0.68 0.70 0.70 0.73 0.78 0.85 0.86 Receivable days 61.31 58.11 63.55 60.03 58.02 54.84 51.03 50.00 48.73 47.26 Inventory Days 87.61 79.59 82.55 73.90 62.69 64.50 66.32 66.44 68.60 67.81 Payable days 39.61 50.47 58.32 55.08 45.81 14.50 22.85 24.79 25.01 28.70 Cash Conversion Cycle 109.31 87.24 87.78 78.85 74.91 104.84 94.50 91.65 92.33 86.37 Total Debt/Equity 0.02 0.02 0.01 0.01 0.02 0.03 0.05 0.12 0.12 0.36 Interest Cover 41.44 46.58 41.36 58.89 82.76 44.94 32.13 16.34 31.91 16.04

Top Investors:

orbimed asia iii mauritius fvci limited

nalanda india equity fund limited

clarus capital i

marval guru fund

pradip bhailal shah

mukund madhusudan kabra

polunin emerging markets small cap fund, llc

investor education and protection fund (iepf)

Annual Reports:

News Update:

Advanced Enzyme - Quarterly Results
10th May 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback